Product Information
IMATINIB MESYLATE 100 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.6632 per EA under NDC 59651024090. Its NADAC has been published 233 times since Feb 10, 2021.
Strength
100 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651024090
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IMATINIB MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA212773On Market Since
7/23/2020
Pharmacological Classes
Price Statistics
The NADAC for IMATINIB MESYLATE 100 MG TAB has been published 233 times since Feb 10, 2021, and over the history we have for it it has declined 78.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6632 per EA |
|---|---|
| All-time high | $3.1369 (Jul 14, 2021) |
| All-time low | $0.3890 (May 22, 2024) |
| 52-week high | $0.9761 |
| 52-week low | $0.6632 |
| Median price | $0.7351 |
| Average price | $0.9470 |
| Largest weekly change | -74.1% (Jun 22, 2022) |
| Weeks tracked | 233 |
| Tracking since | Feb 10, 2021 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IMATINIB MESYLATE 100 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for IMATINIB MESYLATE 100 MG TAB, manufactured by Aurobindo Pharma Limited, is $0.6632 per EA (NDC 59651024090), effective Jun 24, 2026.
How has the price of IMATINIB MESYLATE 100 MG TAB changed over time?
Over the history we have for it, the NADAC for IMATINIB MESYLATE 100 MG TAB has declined 78.9%. It has been tracked across 233 weekly CMS publications since Feb 10, 2021.
What are the highest and lowest recorded NADAC prices for IMATINIB MESYLATE 100 MG TAB?
Since Feb 10, 2021, the NADAC for IMATINIB MESYLATE 100 MG TAB has ranged from a low of $0.3890 (May 22, 2024) to a high of $3.1369 (Jul 14, 2021), with a median of $0.7351 per EA.
Are there cheaper alternatives to IMATINIB MESYLATE 100 MG TAB?
6 NADAC-published products share the same active ingredient, strength, and dosage form as IMATINIB MESYLATE 100 MG TAB, but none are currently priced below it.
Who manufactures IMATINIB MESYLATE 100 MG TAB?
IMATINIB MESYLATE 100 MG TAB (NDC 59651024090) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification